Exome Asset Management LLC Apellis Pharmaceuticals, Inc. Transaction History
Exome Asset Management LLC
- $133 Billion
- Q4 2024
A detailed history of Exome Asset Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 119,467 shares of APLS stock, worth $2.84 Million. This represents 2.86% of its overall portfolio holdings.
Number of Shares
119,467
Previous 100,367
19.03%
Holding current value
$2.84 Million
Previous $2.89 Billion
31.7%
% of portfolio
2.86%
Previous 1.96%
Shares
4 transactions
Others Institutions Holding APLS
# of Institutions
301Shares Held
111MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$290 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$283 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$239 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$229 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$138 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.61B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...